Skip to main content

AgraFlora’s Delta Greenhouse Facility Receives Standard Cultivation License from Health Canada

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc.  (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that Propagation Services Canada Inc., the Company’s flagship cultivation asset located in Delta, British Columbia (the “Delta Facility” or “PSC”) has secured a Standard Cultivation License (the “License”) from Health Canada.
“Obtaining the License at the Delta Facility marks the end of a journey commenced in Q4 2018 and is the key milestone in beginning cannabis sales from what is the 2nd largest and one of the most advanced greenhouses in Canada,” stated Brandon Boddy, AgraFlora Executive Chairman and CEO.  “With license in hand, we’re commencing the cultivation of a curated portfolio of elite live plant genetics that will enable us to execute on a focused strategy of high-potency, low-cost cannabis to drive high-volume value brands from coast to coast.”The Delta Facility’s first phase represents 422,828 sq. ft. of cultivation space utilizing a state-of-the-art pressurized, semi-open Venlo greenhouse design considered to be one of the most technically advanced and environmentally friendly greenhouse platforms in North America and is uniquely located in an agricultural micro-climate on the shores of the Pacific. The Delta Greenhouse is scalable up to 2,200,000 sq. ft.  Key features of the Delta Greenhouse include:Fully integrated on-site natural-gas-powered power plant;Advanced climate and humidity control management infrastructure;Proprietary energy-efficient air exchange to maintain stable climate conditions at a fraction of the cost of traditional HVAC systems;Ebb-and-flow watering systems to enhance complete irrigation recapture and water treatment;Multistage supplemental lighting augmented by natural sunlight to foster optimized illumination equilibrium; andA proprietary ERP system to allow for efficient resource management and cost tracking.A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c2cf8ba1-15ba-43b2-ba1d-5b2daae788faRuben Houweling, general manager of Houweling Nurseries, stated, “Our company brings 40 years of agricultural expertise to PSC, as well as decades of experience within this greenhouse. We have a well-integrated organization with more than 200 employees.  Our facility is located in a unique agricultural micro-climate on the shores of the Pacific Ocean that will help the company produce high-potency, low cost cannabis.”PSC will now commence the cultivation of its curated portfolio of elite live plant genetics (See press release dated February 28, 2020) which were specially curated by an award winning Canadian cultivator with a focus on combining high potency with above-average yields and favourable agricultural traits such as disease and pest resistance.  Combined with the agricultural experience and expertise of the PSC management team, these genetics will support the Company’s strategy of producing high-potency, low cost cannabis to support national value brands.With today’s granting of the standard cultivation license, the company’s consultants, in conjunction with the PSC team, indicate that the inaugural harvest of high potency THC genetics at its Delta greenhouse complex will occur within the fourth quarter of 2020.About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a leading cannabis company building shareholder value through the development of revenue generating operating assets in the global cannabis industry.  AgraFlora is focused primarily on the Canadian cannabis industry; the world’s most advanced and regulated legal cannabis market.  Flagship Canadian assets include: Edibles & Infusions, a fully automated manufacturing facility in Winnipeg, MB for white-label and consumer branded edible production; Propagation Services Canada, a large-scale commercial greenhouse in Delta, BC focused on reshaping the Canadian flower market with high-potency, low cost cannabis flower, and AAA Heidelberg, a craft focused cannabis producer in London, ON. In addition, AgraFlora’s wholly owned subsidiary Farmako GmbH is scaling towards its goal of being Europe’s leading distributor of medical cannabis.  Farmako currently has active distribution operations in Germany and expects to commence active operations in the United Kingdom in 2020. For more information please visit: https://agraflora.com/.About Propagation Services CanadaPropagation Services Canada is a joint-venture formed between AgraFlora and the Houwelings Group, one of North America’s leading producers and innovators in the greenhouse vegetable production industry.  For three generations, Houwelings has been championing innovation in North American vegetable production, holding multiple patents and developing large-scale commercial greenhouses in British Colombia, California and Utah. The Houwelings Group was the first in the USA to utilize combined heat and power co-generation, and the first to develop a proprietary sealed growing technology.  Through the JV, Propagation Services Canada will operate an automated greenhouse facility with an expandable footprint of up to 2,200,000 sq. ft.  Propagation Services Canada is expected to commence cannabis operations and revenue in 2020 with a focus on producing high-potency cannabis at the lowest possible cost to drive margin growth and profitability.ON BEHALF OF THE BOARD OF DIRECTORS

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.